ACM
BMY icon

AlphaCrest Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

AlphaCrest Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,687
Closed -$1.4M – 159
2022
Q3 		$1.4M Sell
19,687
-152,044
-89% -$11M 0.09% 403
2022
Q2 		$13.2M Buy
171,731
+97,581
+132% +$7.43M 0.64% 4
2022
Q1 		$5.42M Sell
74,150
-117,170
-61% -$7.87M 0.3% 46
2021
Q4 		$11.9M Sell
191,320
-37,587
-16% -$2.2M 0.44% 18
2021
Q3 		$13.5M Buy
228,907
+142,613
+165% +$9.39M 0.7% 4
2021
Q2 		$5.77M Sell
86,294
-22,071
-20% -$1.44M 0.25% 81
2021
Q1 		$6.84M Buy
108,365
+32,414
+43% +$2.02M 0.38% 36
2020
Q4 		$4.71M Buy
75,951
+24,977
+49% +$1.54M 0.39% 37
2020
Q3 		$3.07M Buy
50,974
+29,707
+140% +$1.79M 0.33% 34
2020
Q2 		$1.25M Sell
21,267
-25,976
-55% -$1.55M 0.21% 105
2020
Q1 		$2.63M Buy
47,243
+31,612
+202% +$1.93M 0.32% 33
2019
Q4 		$1M Sell
15,631
-24,800
-61% -$1.42M 0.08% 346
2019
Q3 		$2.05M Sell
40,431
-124,312
-75% -$5.84M 0.12% 223
2019
Q2 		$7.47M Buy
164,743
+91,088
+124% +$4.24M 0.65% 4
2019
Q1 		$3.51M Buy
73,655
+48,055
+188% +$2.39M 0.53% 14
2018
Q4 		$1.33M Buy
+25,600
New +$1.38M 0.4% 29

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

AlphaCrest Capital Management's BMY Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 19,687 shares — an estimated $1.4M sold.

AlphaCrest Capital Management first reported a position in BMY in Q4 2018 and held it in 16 quarters. The position peaked at $13.5M in Q3 2021. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 19,687 Bristol-Myers Squibb shares in Q4 2022, an estimated $1.4M.
  • AlphaCrest Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 16 quarters.
  • AlphaCrest Capital Management's Bristol-Myers Squibb position peaked at $13.5M in Q3 2021.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.